"Blogging for Joan" has moved!
www.bloggingforjoan.org and www.bloggingforjoan.com should redirect there automatically.
However, the direct URL is
http://www.gaetafund.org/blogging-for-joan1.html.
See you there!
Showing posts with label News. Show all posts
Showing posts with label News. Show all posts
Friday, September 23, 2011
Thursday, July 14, 2011
Thursday, June 30, 2011
Lung Cancer Controversy Extinguised: CT Scan Versus X-Ray: CT Scan Wins!
Originally published by The Bonnie J. Addario Lung Cancer Foundaton (BJALCF) on June 30th, 2011. The Joan Gaeta Lung Cancer Fund is a proud affiliate of BJALCF, raising money for its research institute, ALCMI.San Francisco-June 29, 2011–The New England Journal of Medicine’s (NEJM) headline today read, “Reduced Lung Cancer Mortality with Low-Dose Computed Tomographic CT Screening,” ending a long controversy over the use of an existing but underutilized early detection tool for those at risk for Lung Cancer. Preliminary results of the National Lung Screening Trial (NLST) were first released on November 4, 2010 and confirmed today. The study of more than 53,000 people who either once smoked or currently smoked found there were 20 percent fewer deaths among those who underwent annual screening with a scanning procedure known as a low-dose helical computed tomography (CT) compared with those who got standard chest X-rays. Click here to read the full article in NEJM.
The findings were so striking that the National Cancer Institute, which helped sponsor the study, halted the eight-year trial early after a panel of experts notified officials about the clear results of an interim analysis and Dr. Varmus released the preliminary results immediately. “Lung cancer is the leading cause of cancer mortality in the U.S. and throughout the world, so a validated approach that can reduce lung cancer mortality by even 20 percent has the potential to spare very significant numbers of people from the ravages of this disease,” said Varmus.
The long-anticipated results were in concert with what the Bonnie J. Addario Lung Cancer Foundation has advocated since its inception, in March 2006.
Bonnie J. Addario, Founder of BJALCF and ALCMI, commented, “This is fantastic news. We knew this, and generated long overdue attention with our national PUBLIC AWARENESS CAMPAIGN to Demand a CT Scan, and our Comprehensive Lung Cancer Screening Program four years ago, which fueled this conversation. Today’s NLST study results support and confirm our intellectual, scientific, personal and practical mission to significantly increase the survival rate for Lung Cancer for the first time in forty years.”
“This is a landmark study and a landmark day for millions of people at risk for Lung Cancer,” said David Jablons, MD, Professor and Chief of Thoracic Surgery, University of California San Francisco (UCSF) and co-founder of the Bonnie J. Addario Lung Cancer Foundation (BJALCF). “This study vindicates numerous pioneering investigators worldwide who have advocated for the utility and benefit of low-dose spiral CT scans for the early detection of Lung Cancer. The results announced today in the New England Journal of Medicine lay to rest the question of using the low-dose spiral CT scan for the at-risk population. CT scans can save lives. It is our hope that third-party payors and insurers will embrace these results which will lead to more screening, a new standard of care and most important, saving lives.”
Scott Santarella, BJALCF’s President and CEO, former President and CEO of the American Lung Cancer Association in New York and former COO of the Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC), stated, “Today's announcement validates our belief in utilizing the tools available to the lung cancer community to diagnose patients as early as possible because we know it saves lives.”
Bonnie J. Addario is a seven-year Stage IIIB CT-scanned Lung Cancer Survivor. She, BJALCF and ALCMI will be presenting at the International Association for the Study of Lung Cancer (IASLC) 14th Annual World Conference in Amsterdam on July 5, 2011. BJALCF and ALCMI are the only non-profit lung cancer foundations ever to have been invited as guests to present a Satellite Symposium at an IASLC World Conference. The Symposium is entitled, “The Way Forward.”
About the Bonnie J. Addario Lung Cancer Foundation (BJALCF)
BJALCF is THE patient-founded, patient-focused voice relentlessly working to increase the survival of Lung Cancer worldwide through early detection, awareness and funding for research. BJALCF was established in 2006 as a 501(c)(3) non-profit organization and has raised over six million dollars for Lung Cancer Research. Contact: Sheila Von Driska, Executive Director, sheila@lungcancerfoundation.org 415.357.1278
About the Addario Lung Cancer Medical Institute (ALCMI)
ALCMI was established in 2008 as a 501(c)(3) non-profit organization with the ultimate goal of significantly impacting survival by catalyzing and accelerating discovery of new and more effective treatment options for all lung cancer patients.
Contact: Steven Young, President, syoung@alcmi.net 203.247.9035
About The Joan Gaeta Lung Cancer Fund
A lifelong non-smoker, Joan Gaeta was a devoted wife, teacher, and mother of five. Diagnosed with Lung Cancer in early 2004, she fought a three and a half year battle before succumbing in July of 2007.
During that time, Joan stressed the need for greater awareness of Lung Cancer, the number one cancer killer in the world, which has a very low survival rate and a tragic lack of research funds. She was most passionate about eliminating the stigma of the disease, since lung cancer also strikes non-smokers at a high rate.
The Joan Gaeta Lung Cancer Fund was created in the fall of 2007 as The Joan Gaeta Lung Cancer Foundation by her husband and children to raise awareness of the disease, to educate the public, and to be an advocate for research. We also strive to eliminate the stigma of lung cancer and to support survivors and their loved ones in our local community.
In July of 2010, they re-launched as The Joan Gaeta Lung Cancer Fund benefiting the Addario Lung Cancer Medical Institute. Their ultimate goal remains the same: “to eradicate lung cancer.” By partnering with one significant research initiative, they can make a much greater impact in wiping out lung cancer.
Contact: gaetafund@gmail.com or (404) 987-0792
Monday, June 13, 2011
The Divas are on Atlanta TV
Look for the Divas on WXIA-Ch. 11 tomorrow, "Atlanta & Co" -- 11 am, June 14. And then again June 19, WSB's "People 2 People" at 6:30 am. The concert is a powerhouse, tickets are moving fast...The Buckhead Theatre and Gwen Hughes appears on behalf of The Joan Gaeta Lung Cancer Fund.
They are Divas with a Cause!
They are Divas with a Cause!
Thursday, June 9, 2011
Jill's Legacy: Please watch an important and very inspirational video feature from ESPN.
The video can be found here: http://jglcf.org/JillCostello.aspx
This ESPN feature profiles of 22-year-old college student and athlete at U.C. Berkeley, Jillian Costello, who lost her battle with lung cancer in June of 2010, just one year after being diagnosed.
Jill's story is an inspirational one that you do not want to miss. Please consider sharing this with friends and family.
http://www.jillslegacy.org/
http://www.thelungcancerfoundation.org/
http://www.forjoan.org/
This ESPN feature profiles of 22-year-old college student and athlete at U.C. Berkeley, Jillian Costello, who lost her battle with lung cancer in June of 2010, just one year after being diagnosed.
Jill's story is an inspirational one that you do not want to miss. Please consider sharing this with friends and family.
http://www.jillslegacy.org/
http://www.thelungcancerfoundation.org/
http://www.forjoan.org/
Sunday, April 24, 2011
Abby's Dream Walk - April 30th - Macon, Georgia
Originally published at www.newscentralga.com
By Michelle Quesada
April 22, 2011
Ever since the Twilight Mom's of Middle Georgia transformed Abby Wilson's room into wolf pack territory, they have gone above and beyond to help this brave 13-year-old girl battling lung cancer.
They hosted a yard sale in early April to raise money to send Abby and her mom to Forks, Washington where the Twilight movies were filmed and now they are planning a walk to make Abby's dream to bring awareness come true.
"We got to know Abby and we just fell in love with her and wanted to do anything that we could do anything that we can do to support her," says Cindy Adrien, Chair of the Twilight Moms of Middle Georgia.
And so the community is coming together to organize a lung cancer awareness walk at Tattnall Square Academy on Saturday April 30th, but Abby's dream doesn't stop there. The Twilight Moms along with others are bringing Booboo Stewart, the youngest wolf in the pack of the Twilight series, to Abby's Dream Walk.
"My best friend Brittney is kind of jealous, but just to know that she'll be with me on that day of the walk is pretty cool and she'll get to meet him too," says Abby Wilson.
Not to mention Abby will get to walk around the track with Booboo Stewart, but the community will alo have a chance to meet him and take photos at the walk and at a meet and greet at Jocks and Jills.
"It's incredible because she says this whole community not just us Twilight Moms, but the community itself, coming behind her and saying 'you're amazing, you're a strong girl," says Adrien.
And Tina Wilson, Abby's mother, is grateful to see this dream come true for her daughter.
"They love her and I know I see that when she walks in the room and they see her and they're like 'oh Abby' and they hug her and they love on her and that means lot,' says Tina Wilson, Abby's mom.
And as for Abby, her room shows that she 'runs with wolves' but now she actually gets to walk with one.
Abby's Dream Walk takes place from 9 a.m. to 1 p.m. at Tattnall Square Academy on Saturday April 30th.
The Meet and Greet will take place Friday April 29th at 6:30 p.m. at Jocks and Jills.
Learn more at www.AbbysDream.com!
By Michelle Quesada
April 22, 2011
Ever since the Twilight Mom's of Middle Georgia transformed Abby Wilson's room into wolf pack territory, they have gone above and beyond to help this brave 13-year-old girl battling lung cancer.
They hosted a yard sale in early April to raise money to send Abby and her mom to Forks, Washington where the Twilight movies were filmed and now they are planning a walk to make Abby's dream to bring awareness come true.
"We got to know Abby and we just fell in love with her and wanted to do anything that we could do anything that we can do to support her," says Cindy Adrien, Chair of the Twilight Moms of Middle Georgia.
And so the community is coming together to organize a lung cancer awareness walk at Tattnall Square Academy on Saturday April 30th, but Abby's dream doesn't stop there. The Twilight Moms along with others are bringing Booboo Stewart, the youngest wolf in the pack of the Twilight series, to Abby's Dream Walk.
"My best friend Brittney is kind of jealous, but just to know that she'll be with me on that day of the walk is pretty cool and she'll get to meet him too," says Abby Wilson.
Not to mention Abby will get to walk around the track with Booboo Stewart, but the community will alo have a chance to meet him and take photos at the walk and at a meet and greet at Jocks and Jills.
"It's incredible because she says this whole community not just us Twilight Moms, but the community itself, coming behind her and saying 'you're amazing, you're a strong girl," says Adrien.
And Tina Wilson, Abby's mother, is grateful to see this dream come true for her daughter.
"They love her and I know I see that when she walks in the room and they see her and they're like 'oh Abby' and they hug her and they love on her and that means lot,' says Tina Wilson, Abby's mom.
And as for Abby, her room shows that she 'runs with wolves' but now she actually gets to walk with one.
Abby's Dream Walk takes place from 9 a.m. to 1 p.m. at Tattnall Square Academy on Saturday April 30th.
The Meet and Greet will take place Friday April 29th at 6:30 p.m. at Jocks and Jills.
Learn more at www.AbbysDream.com!
Monday, April 18, 2011
13-Year-Old Battles Lung Cancer
Abby Wilson is 13 and has had lung cancer for 4 years! She is a strong and amazing girl! Her family and friends want people to know that lung cancer can affect people of all ages (even 9 year olds!), regardless of whether they have smoked in their life or not. Abby's Dream was formed to hold walks and events to provide awareness and support for her family.
Their mission is to bring awareness that lung cancer affects people of all ages and can affect people regardless if they have ever smoked!
They plan to hold events to provide awareness about lung cancer and to help support Abby's family as they fight this dreaded disease!
The first walk for Abby's Dream is scheduled for Saturday, April 30th at Tattnall Square Academy in Macon, Georgia. Registration is at 9 a.m. with walk beginning at 10:00 a.m. and ending at 1:00 p.m. with closing remarks. Make plans to come out and walk for Abby!
Email: cindyadrien@twilightmomsofmiddlega.com
Phone: 478-951-4311
Website: http://www.abbysdream.com
Friday, April 15, 2011
LUNG CANCER ALLIANCE ANNOUNCES ADDITIONAL $12.8 MILLION IN FEDERAL RESEARCH FUNDING FOR LUNG CANCER
Brings total to date to $47.8 million.
Funding approved in FY2011 budget compromise via the Department of Defense Lung Cancer Research Program.
WASHINGTON, DC [Thursday, April 14, 2011]--Today, Lung Cancer Alliance (LCA) announced that its efforts to secure increased federal research funding for lung cancer achieved another victory as an additional $12.8 million was included in the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) which was part of the FY2011 budget compromise approved by Congress. The President is expected to sign it into law tonight.
The FY 2011 budget compromise plan reduces federal agency budgets by $38 billion and averted a government shutdown.
The $12.8 million in research funding is in addition to $35 million secured to date by LCA since it first established the DOD lung cancer research pipeline in 2009 which targets research for early detection with special emphasis on high risk military.
“We are proud to share that to date we have secured $47.8 million for lung cancer research funding via this investigative pipeline”, said Laurie Fenton-Ambrose, President and CEO of LCA. This has been the focus of our core mission from day one and we will continue these efforts for patients and survivors as well as our research community. I thank our congressional leadership for understanding the need and electing to continue support for this program. "
Lung cancer is the leading cause of cancer death among men and women and every ethnic group and among our military who are at an increased risk in comparison to their civilian counterparts. Lung cancer has a 15% 5-year survival rate with the vast majority of cases found late stage. In addition, 80% of those diagnosed with lung cancer today are former or non-smokers.
Military personnel have a higher exposure to lung cancer carcinogens and thus are more susceptible than the general public. The FY2011 language calls for continued research focus on screening and early disease management, especially among high risk military. For more information click here.
Lung Cancer Alliance is the only organization dedicated exclusively to providing patient support and advocacy for all those either living with or at risk for lung cancer. Lung Cancer remains committed to leading the movement to reverse decades of stigma and neglect by empowering patients, elevating awareness and changing health policy.
Follow Lung Cancer Alliance on Facebook: www.facebook.com/lungcanceralliance.
[ Keep up the good work, LCA! ]
Funding approved in FY2011 budget compromise via the Department of Defense Lung Cancer Research Program.
WASHINGTON, DC [Thursday, April 14, 2011]--Today, Lung Cancer Alliance (LCA) announced that its efforts to secure increased federal research funding for lung cancer achieved another victory as an additional $12.8 million was included in the Department of Defense (DOD) Congressionally Directed Medical Research Program (CDMRP) which was part of the FY2011 budget compromise approved by Congress. The President is expected to sign it into law tonight.
The FY 2011 budget compromise plan reduces federal agency budgets by $38 billion and averted a government shutdown.
The $12.8 million in research funding is in addition to $35 million secured to date by LCA since it first established the DOD lung cancer research pipeline in 2009 which targets research for early detection with special emphasis on high risk military.
“We are proud to share that to date we have secured $47.8 million for lung cancer research funding via this investigative pipeline”, said Laurie Fenton-Ambrose, President and CEO of LCA. This has been the focus of our core mission from day one and we will continue these efforts for patients and survivors as well as our research community. I thank our congressional leadership for understanding the need and electing to continue support for this program. "
Lung cancer is the leading cause of cancer death among men and women and every ethnic group and among our military who are at an increased risk in comparison to their civilian counterparts. Lung cancer has a 15% 5-year survival rate with the vast majority of cases found late stage. In addition, 80% of those diagnosed with lung cancer today are former or non-smokers.
Military personnel have a higher exposure to lung cancer carcinogens and thus are more susceptible than the general public. The FY2011 language calls for continued research focus on screening and early disease management, especially among high risk military. For more information click here.
Lung Cancer Alliance is the only organization dedicated exclusively to providing patient support and advocacy for all those either living with or at risk for lung cancer. Lung Cancer remains committed to leading the movement to reverse decades of stigma and neglect by empowering patients, elevating awareness and changing health policy.
Follow Lung Cancer Alliance on Facebook: www.facebook.com/lungcanceralliance.
[ Keep up the good work, LCA! ]
Friday, April 8, 2011
Innaugural Dancing for Joan Emcee Holds Seminar About Lung Cancer
“Dr. Morosini is well known nationally. She's an expert in lung cancer particularly in women with lung cancer,” says Diane Fletcher, CEO of the Southwest Georgia Cancer Coalition. “Part of the work of the cancer coalition is to bring opportunities for local health care professionals to be able to have access to this type of information without having to leave the area.”
Read the entire story and view the video at http://www.mysouthwestga.com/news/story.aspx?id=602745
Dr. Morosini was the emcee of our inaugural Dancing for Joan event in 2008.
Tuesday, March 29, 2011
THE JOAN GAETA LUNG CANCER FUND RAISES $15,000 FOR ALCMI
4th Annual “Dancing for Joan” Gala A Huge Success
FOR IMMEDIATE RELEASE
ATLANTA, GA. March 29, 2011: For the fourth consecutive year, The Joan Gaeta Lung Cancer Fund’s Annual “Dancing for Joan” event was a huge success, committing $15,000 to international Lung Cancer research through the Addario Lung Cancer Medical Institute (ALMCI).
CNN Anchor Nancy Grace served again this year as the evening’s emcee for a crowd of more than 200 people who came together on February 26, 2011 at the Pavillion of East Cobb in Marietta, Georgia.
Also returning this year was the event's Honorary Chairman Dr. Paul Scheinberg, Chief of Staff at Saint Joseph's Hospital in Atlanta. This year's annual Hummingbird Award for Dedication was presented to Alice Kerber, RN - also of Saint Joseph's Hospital - for her tireless work as a Lung Cancer advocate and oncology navigator.
“We are very excited about the partnership with ALMCI and for what our annual event was able to accomplish,” says Joe Gaeta, president of The Joan Gaeta Lung Cancer Fund, and son of the late Joan Gaeta, in whose memory the organization was founded. “We are confident that our supporter’s generous donations will make a deep and immediate impact with ALCMI.”
In July of 2010, the Gaetas announced their formal partnership with The Addario Lung Cancer Medical Institute, committing 85 percent of their net proceeds to the excellent work ALCMI is doing. Remaining funds are used in metro Atlanta for an annual awareness campaign and to sponsor the Lung Cancer support group.
“We are deeply thankful to the Gaeta Family for their commitment to ending Lung Cancer in Joan's memory,” says Bonnie J. Addario, founder. “It is with partners like the Gaeta Fund that will allow ALCMI to begin to raise the 'curability' of Lung Cancer in a significant way.”
About The Joan Gaeta Lung Cancer Fund
A lifelong non-smoker, Joan Gaeta was a devoted wife, teacher, and mother of five. Diagnosed with Lung Cancer in early 2004, she fought a three and a half year battle before succumbing in July of 2007.
During that time, Joan stressed the need for greater awareness of Lung Cancer, the number one cancer killer in the world, which has a very low survival rate and a tragic lack of research funds. She was most passionate about eliminating the stigma of the disease, since lung cancer also strikes non-smokers at a high rate.
The Joan Gaeta Lung Cancer Fund was created in the fall of 2007 as The Joan Gaeta Lung Cancer Foundation by her husband and children to raise awareness of the disease, to educate the public, and to be an advocate for research. We also strive to eliminate the stigma of lung cancer and to support survivors and their loved ones in our local community.
In July of 2010, they re-launched as The Joan Gaeta Lung Cancer Fund benefiting the Addario Lung Cancer Medical Institute. Their ultimate goal remains the same: “to eradicate lung cancer.” By partnering with one significant research initiative, they can make a much greater impact in wiping out lung cancer.
www.forjoan.org
About The Addario Lung Cancer Medical Institute (ALCMI)
The Addario Lung Cancer Medical Institute (ALCMI) is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for Lung Cancer patients.
For more information Contact:
www.alcmi.net
FOR IMMEDIATE RELEASE
ATLANTA, GA. March 29, 2011: For the fourth consecutive year, The Joan Gaeta Lung Cancer Fund’s Annual “Dancing for Joan” event was a huge success, committing $15,000 to international Lung Cancer research through the Addario Lung Cancer Medical Institute (ALMCI).
CNN Anchor Nancy Grace served again this year as the evening’s emcee for a crowd of more than 200 people who came together on February 26, 2011 at the Pavillion of East Cobb in Marietta, Georgia.
Also returning this year was the event's Honorary Chairman Dr. Paul Scheinberg, Chief of Staff at Saint Joseph's Hospital in Atlanta. This year's annual Hummingbird Award for Dedication was presented to Alice Kerber, RN - also of Saint Joseph's Hospital - for her tireless work as a Lung Cancer advocate and oncology navigator.
“We are very excited about the partnership with ALMCI and for what our annual event was able to accomplish,” says Joe Gaeta, president of The Joan Gaeta Lung Cancer Fund, and son of the late Joan Gaeta, in whose memory the organization was founded. “We are confident that our supporter’s generous donations will make a deep and immediate impact with ALCMI.”
In July of 2010, the Gaetas announced their formal partnership with The Addario Lung Cancer Medical Institute, committing 85 percent of their net proceeds to the excellent work ALCMI is doing. Remaining funds are used in metro Atlanta for an annual awareness campaign and to sponsor the Lung Cancer support group.
“We are deeply thankful to the Gaeta Family for their commitment to ending Lung Cancer in Joan's memory,” says Bonnie J. Addario, founder. “It is with partners like the Gaeta Fund that will allow ALCMI to begin to raise the 'curability' of Lung Cancer in a significant way.”
About The Joan Gaeta Lung Cancer Fund
A lifelong non-smoker, Joan Gaeta was a devoted wife, teacher, and mother of five. Diagnosed with Lung Cancer in early 2004, she fought a three and a half year battle before succumbing in July of 2007.
During that time, Joan stressed the need for greater awareness of Lung Cancer, the number one cancer killer in the world, which has a very low survival rate and a tragic lack of research funds. She was most passionate about eliminating the stigma of the disease, since lung cancer also strikes non-smokers at a high rate.
The Joan Gaeta Lung Cancer Fund was created in the fall of 2007 as The Joan Gaeta Lung Cancer Foundation by her husband and children to raise awareness of the disease, to educate the public, and to be an advocate for research. We also strive to eliminate the stigma of lung cancer and to support survivors and their loved ones in our local community.
In July of 2010, they re-launched as The Joan Gaeta Lung Cancer Fund benefiting the Addario Lung Cancer Medical Institute. Their ultimate goal remains the same: “to eradicate lung cancer.” By partnering with one significant research initiative, they can make a much greater impact in wiping out lung cancer.
www.forjoan.org
About The Addario Lung Cancer Medical Institute (ALCMI)
The Addario Lung Cancer Medical Institute (ALCMI) is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for Lung Cancer patients.
For more information Contact:
www.alcmi.net
Monday, March 14, 2011
Tuesday, March 8, 2011
The Bonnie J. Addario Lung Cancer Foundation Introduces Jill’s Legacy
[Originally published at www.bjalcf.org on March 7, 2011.]
Group of young adults takes aim at the world’s #1 cancer killer
San Francisco, CA, March 8, 2011/PRNewsire-USNewswire/—The Bonnie J. Addario Lung Cancer Foundation (BJALCF), a worldwide leader in efforts to eliminate Lung Cancer, announced today that they have launched the creation of a new Advisory Board made up of 21 promising young professionals who have each been personally touched by Lung Cancer. The Board has been called “Jill’s Legacy” in memorial of the 22-year-old college student and athlete at U.C. Berkeley, Jillian Costello, who lost her battle with Lung Cancer in June of 2010, just one year after being diagnosed.
What’s this group’s mission? Simple: to be the driving force in significantly increasing the stagnant 15.5% survival rate of the world’s number one cancer killer—Lung Cancer.
BJALCF namesake and Chairman of the Board, Bonnie Addario, believes they are just the people to do it, saying,
“I am inspired and extremely hopeful about the message that these incredible young people can send to the world about Lung Cancer. They can unearth the truth about this disease and substantially impact funding for research.”
Echoing Bonnie’s enthusiasm is BJALCF’s President and CEO Scott Santarella, saying, “Our group of young adults is incredibly tech savvy, they have embraced the give-back philosophy and are extremely creative and energetic. I have no doubt they will help us create new initiatives to help Lung Cancer patients and their families.”

With its oldest member just 25-years-old, this Board of empowered young adults is largely made up of Jill’s closest friends and loved ones. Bryce Atkinson, Jill’s long-time boyfriend, will serve on the Executive Committee as President of the Board. Other Executive Committee members include Jessica Morello, Jill’s cousin who will serve as Vice President; Kristina Renda, High School classmate of Jill’s who also lost her father and grandmother to Lung Cancer and will serve as Secretary; K.C. Oakley, Jill’s closest friend at U.C. Berkeley, who will serve as Treasurer; Taylor Bell, a North Carolina-based 24-year-old Lung Cancer survivor herself; Sahil Patel, who lost his mother to the disease and is studying to be a thoracic surgeon in her honor; Darby Anderson, one of Jill’s closest friends who has dedicated her life to the cause; and Elizabeth Button, Jill’s life-long friend who is studying Law in San Francisco.
The Board will also consist of six other committees: Science and Research, “Fun” Raising, Finance, Corporate Sponsorship, Public Awareness and Social Media. Members of each committee are also friends of Jill who want to be part of the elimination of the disease that took their young friend from them too soon.
“Essentially, we want to make a change in the way Lung Cancer is viewed in society and treated in medicine. While other cancers have benefitted from modern science and research and exceeded survival rates of 95%, the survival rate for Lung Cancer hasn’t budged from 15.5% in 40 years. That is unacceptable to us and that’s something we have to change” says Jill’s Legacy Executive Committee member, Kristina Renda.
These young people have all seen first-hand that anyone can get Lung Cancer, not just smokers. Through various educational vehicles and fund-raising efforts, they are out to spread the word.
“They say that wisdom comes with age. I think in this age of information technology, wisdom comes quicker for the younger generations and it comes without past prejudice,” says Sheila Von Driska, BJALCF Executive Director, “The members of Jill’s Legacy have no patience or time for a stigma that has kept Lung Cancer in the shadows for over 40 years. I believe Jill’s Legacy is revolutionizing the way society views Lung Cancer and because of them, we’re going to witness a rapid intelligent change in the survival rate of Lung Cancer.”
For more information, or to invest in Jill’s Legacy, email Sheila Von Driska, Executive Director, Bonnie J. Addario Lung Cancer Foundation at sheila@lungcancerfoundation.org or call 415.357.1278.
Read more about Jillian Costello as seen in Sports Illustrated (Click here).
Jill’s Legacy Advisory Board Members (as of March 8, 2011)
Bryce Atkinson, President
Jessica Morello, Vice President
Kristina Renda, Secretary
K.C. Oakley, Treasurer
Darby Anderson
Gabriel Baumgaertner
Erica Bellis
Taylor Bell
Elizabeth Button
Maggie Eisenberg
Nathan Floyd
Emily Frumberg
Kelcey Harrison
Mihir Kshirsagar
Danielle Michelsen
Siobhan Murphy
Sahil Patel
Alli Paver
Angela Strohbeck
Gianna Toboni
Adeeti Ullal
Group of young adults takes aim at the world’s #1 cancer killer
San Francisco, CA, March 8, 2011/PRNewsire-USNewswire/—The Bonnie J. Addario Lung Cancer Foundation (BJALCF), a worldwide leader in efforts to eliminate Lung Cancer, announced today that they have launched the creation of a new Advisory Board made up of 21 promising young professionals who have each been personally touched by Lung Cancer. The Board has been called “Jill’s Legacy” in memorial of the 22-year-old college student and athlete at U.C. Berkeley, Jillian Costello, who lost her battle with Lung Cancer in June of 2010, just one year after being diagnosed.
What’s this group’s mission? Simple: to be the driving force in significantly increasing the stagnant 15.5% survival rate of the world’s number one cancer killer—Lung Cancer.
BJALCF namesake and Chairman of the Board, Bonnie Addario, believes they are just the people to do it, saying,
“I am inspired and extremely hopeful about the message that these incredible young people can send to the world about Lung Cancer. They can unearth the truth about this disease and substantially impact funding for research.”
Echoing Bonnie’s enthusiasm is BJALCF’s President and CEO Scott Santarella, saying, “Our group of young adults is incredibly tech savvy, they have embraced the give-back philosophy and are extremely creative and energetic. I have no doubt they will help us create new initiatives to help Lung Cancer patients and their families.”
With its oldest member just 25-years-old, this Board of empowered young adults is largely made up of Jill’s closest friends and loved ones. Bryce Atkinson, Jill’s long-time boyfriend, will serve on the Executive Committee as President of the Board. Other Executive Committee members include Jessica Morello, Jill’s cousin who will serve as Vice President; Kristina Renda, High School classmate of Jill’s who also lost her father and grandmother to Lung Cancer and will serve as Secretary; K.C. Oakley, Jill’s closest friend at U.C. Berkeley, who will serve as Treasurer; Taylor Bell, a North Carolina-based 24-year-old Lung Cancer survivor herself; Sahil Patel, who lost his mother to the disease and is studying to be a thoracic surgeon in her honor; Darby Anderson, one of Jill’s closest friends who has dedicated her life to the cause; and Elizabeth Button, Jill’s life-long friend who is studying Law in San Francisco.
The Board will also consist of six other committees: Science and Research, “Fun” Raising, Finance, Corporate Sponsorship, Public Awareness and Social Media. Members of each committee are also friends of Jill who want to be part of the elimination of the disease that took their young friend from them too soon.
“Essentially, we want to make a change in the way Lung Cancer is viewed in society and treated in medicine. While other cancers have benefitted from modern science and research and exceeded survival rates of 95%, the survival rate for Lung Cancer hasn’t budged from 15.5% in 40 years. That is unacceptable to us and that’s something we have to change” says Jill’s Legacy Executive Committee member, Kristina Renda.
These young people have all seen first-hand that anyone can get Lung Cancer, not just smokers. Through various educational vehicles and fund-raising efforts, they are out to spread the word.
“They say that wisdom comes with age. I think in this age of information technology, wisdom comes quicker for the younger generations and it comes without past prejudice,” says Sheila Von Driska, BJALCF Executive Director, “The members of Jill’s Legacy have no patience or time for a stigma that has kept Lung Cancer in the shadows for over 40 years. I believe Jill’s Legacy is revolutionizing the way society views Lung Cancer and because of them, we’re going to witness a rapid intelligent change in the survival rate of Lung Cancer.”
For more information, or to invest in Jill’s Legacy, email Sheila Von Driska, Executive Director, Bonnie J. Addario Lung Cancer Foundation at sheila@lungcancerfoundation.org or call 415.357.1278.
Read more about Jillian Costello as seen in Sports Illustrated (Click here).
Jill’s Legacy Advisory Board Members (as of March 8, 2011)
Bryce Atkinson, President
Jessica Morello, Vice President
Kristina Renda, Secretary
K.C. Oakley, Treasurer
Darby Anderson
Gabriel Baumgaertner
Erica Bellis
Taylor Bell
Elizabeth Button
Maggie Eisenberg
Nathan Floyd
Emily Frumberg
Kelcey Harrison
Mihir Kshirsagar
Danielle Michelsen
Siobhan Murphy
Sahil Patel
Alli Paver
Angela Strohbeck
Gianna Toboni
Adeeti Ullal
Wednesday, March 2, 2011
Important Information and Eye-Opening Statistics
Originally published at About.com on March 2, 2011
I'm often surprised by the response I get when I mention that the majority of people who develop lung cancer now are non-smokers. "What? You've gotta be kidding! Where did you hear that?"
Yet it's true. Lung cancer occurs more often in people who've already kicked the habit -- and that act of courage may have occurred well in the past.
A new study gives us numbers to talk about. Researchers looked at over 600 people who were referred for lung cancer surgery and who were asked the question; "Did you smoke, and if so, when did you quit?"
Of these patients 77% had a history of smoking in the past, but only 11% were current smokers. The "average" patient had quit smoking 18 years before the diagnosis of lung cancer. The former smokers were broken down further by how long they had been "smoking abstinent":
I'm often surprised by the response I get when I mention that the majority of people who develop lung cancer now are non-smokers. "What? You've gotta be kidding! Where did you hear that?"
Yet it's true. Lung cancer occurs more often in people who've already kicked the habit -- and that act of courage may have occurred well in the past.
A new study gives us numbers to talk about. Researchers looked at over 600 people who were referred for lung cancer surgery and who were asked the question; "Did you smoke, and if so, when did you quit?"
Of these patients 77% had a history of smoking in the past, but only 11% were current smokers. The "average" patient had quit smoking 18 years before the diagnosis of lung cancer. The former smokers were broken down further by how long they had been "smoking abstinent":
- 14% had been smoke free for less than a year
- 27% were smoke free for 1 to 10 years
- 21% were smoke free for 10 to 20 years
- 16% were smoke free for 20 to 30 years
- 11% were smoke free for 30 to 40 years
- 10% were smoke free for 40 to 50 years
Why is this important?
Lung cancer is most treatable in the early stages of the disease. Since we don't have a widely available safe and effective screening test at this time, it's important for individuals at risk to be aware of the symptoms of lung cancer.
It's also important as we work to dispel the stigma of lung cancer. How many of us have tactlessly made a comment about smoking to someone newly diagnosed with lung cancer?
Part of me hesitated to write about this study. I don't want to throw a black cloud over current smokers who are trying to quit. Because even if people who smoked in the past are at greater risk than never smokers for developing lung cancer, quitting makes a difference. What do the statistics say about quitting or cutting down upon subsequent lung cancer risk?
If you smoked at some time in the past (or even if not because never smokers get lung cancer too...), take a minute to become familiar with the symptoms of lung cancer.
- What are Early Symptoms of Lung Cancer?
- Symptoms of Lung Cancer in Women
- Symptoms of Lung Cancer in Men
Source: Mong, C. et al. High Prevalence of Lung Cancer in a Surgical Cohort of Lung Cancer Patients a Decade After Smoking Cessation. Journal of Cardiothoracic Surgery. 2011. 6(1):10.
Tuesday, February 22, 2011
The Bonnie J. Addario Lung Cancer Foundation Names Scott Santarella as New President and CEO
Former President and CEO of the American Lung Association (NY) to Lead Foundation's Worldwide Efforts
SAN FRANCISCO, Feb. 22, 2011 /PRNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (BJALCF), a global leader in efforts to eradicate lung cancer, today announced that it has named Scott Santarella as its new President and CEO.
Santarella, former President and CEO of the American Lung Association in New York and former COO of the Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) will step into the previous role of Bonnie J. Addario, who is now Chairman of the Board.
Mr. Santarella brings more than 20 years of experience as a senior executive with a proven track record in innovative marketing, successful management of fundraising, and raising awareness for underfunded diseases and causes. His knowledge of science and research combined with the highest regard to ethics and constituent service has driven his successful track record of raising more than $250 million in his previous leadership roles.
Prior to his senior posts at the MMRF and MMRC, Mr. Santarella was highly successful in several key roles at the Educational Foundation of America, Earthplace, Knights of Columbus and the March of Dimes Birth Defects Foundation. He graduated Cum Laude at the University of Massachusetts with a B.A. in Journalism and completed the Executive Leadership Program at Harvard Business School.
"Our foundation is enormously fortunate to have Scott take the helm," says Bonnie J. Addario, BJALCF founder and lung cancer survivor. "Not only does he bring the depth and breadth of financial and management expertise that will be instrumental in our expansion, he's a fundraising champion. He managed to lift an annual non-profit's combined revenue to 300 percent, while maintaining annual administrative expenses at seven percent. I am proud of what we've built so far, and I am honored to have Scott join our movement at this point in time. I want to see tangible change in the survival rate of lung cancer in my lifetime, and the addition of his leadership experience renews my confidence that this dream will become a reality."
"It's a real honor for me," says Scott, "to have been selected as the President and CEO of BJALCF. I admire and respect Bonnie a great deal and have been a huge fan of the foundation's innovative work and business focus. I am truly looking forward to working with the foundation's team to take the organization to the next level."
"Funding for the Number One Cancer Killer is more than forty years past due," says Sheila Von Driska, BJALCF Executive Director. "With an alarming incidence of lung cancer in never smokers on the rise, it's time to take this bully by the horn and take it down. Scott's experience is a fresh new kick-start for the second round in this worldwide battle. We look forward to letting lung cancer know it's 'game over.'"
About the Bonnie J. Addario Lung Cancer Foundation (BJALCF)
BJALCF is one of the largest philanthropies and recognized force devoted exclusively to eradicating lung cancer through research, early detection, education, prevention, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established in 2006 as a 501(c)(3) non-profit organization and has raised over five million dollars for Lung Cancer.
About the Addario Lung Cancer Medical Institute (ALCMI)
The Addario Lung Cancer Medical Institute (ALCMI) was established in 2008 as a 501(c)(3) non-profit organization with the ultimate goal of significantly impacting survival by catalyzing and accelerating discovery of new and more effective treatment options for all lung cancer patients.
SOURCE Bonnie J. Addario Lung Cancer Foundation
SAN FRANCISCO, Feb. 22, 2011 /PRNewswire/ -- The Bonnie J. Addario Lung Cancer Foundation (BJALCF), a global leader in efforts to eradicate lung cancer, today announced that it has named Scott Santarella as its new President and CEO.
Santarella, former President and CEO of the American Lung Association in New York and former COO of the Multiple Myeloma Research Foundation (MMRF) and Multiple Myeloma Research Consortium (MMRC) will step into the previous role of Bonnie J. Addario, who is now Chairman of the Board.
Mr. Santarella brings more than 20 years of experience as a senior executive with a proven track record in innovative marketing, successful management of fundraising, and raising awareness for underfunded diseases and causes. His knowledge of science and research combined with the highest regard to ethics and constituent service has driven his successful track record of raising more than $250 million in his previous leadership roles.
Prior to his senior posts at the MMRF and MMRC, Mr. Santarella was highly successful in several key roles at the Educational Foundation of America, Earthplace, Knights of Columbus and the March of Dimes Birth Defects Foundation. He graduated Cum Laude at the University of Massachusetts with a B.A. in Journalism and completed the Executive Leadership Program at Harvard Business School.
"Our foundation is enormously fortunate to have Scott take the helm," says Bonnie J. Addario, BJALCF founder and lung cancer survivor. "Not only does he bring the depth and breadth of financial and management expertise that will be instrumental in our expansion, he's a fundraising champion. He managed to lift an annual non-profit's combined revenue to 300 percent, while maintaining annual administrative expenses at seven percent. I am proud of what we've built so far, and I am honored to have Scott join our movement at this point in time. I want to see tangible change in the survival rate of lung cancer in my lifetime, and the addition of his leadership experience renews my confidence that this dream will become a reality."
"It's a real honor for me," says Scott, "to have been selected as the President and CEO of BJALCF. I admire and respect Bonnie a great deal and have been a huge fan of the foundation's innovative work and business focus. I am truly looking forward to working with the foundation's team to take the organization to the next level."
"Funding for the Number One Cancer Killer is more than forty years past due," says Sheila Von Driska, BJALCF Executive Director. "With an alarming incidence of lung cancer in never smokers on the rise, it's time to take this bully by the horn and take it down. Scott's experience is a fresh new kick-start for the second round in this worldwide battle. We look forward to letting lung cancer know it's 'game over.'"
About the Bonnie J. Addario Lung Cancer Foundation (BJALCF)
BJALCF is one of the largest philanthropies and recognized force devoted exclusively to eradicating lung cancer through research, early detection, education, prevention, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established in 2006 as a 501(c)(3) non-profit organization and has raised over five million dollars for Lung Cancer.
About the Addario Lung Cancer Medical Institute (ALCMI)
The Addario Lung Cancer Medical Institute (ALCMI) was established in 2008 as a 501(c)(3) non-profit organization with the ultimate goal of significantly impacting survival by catalyzing and accelerating discovery of new and more effective treatment options for all lung cancer patients.
SOURCE Bonnie J. Addario Lung Cancer Foundation
Monday, February 21, 2011
Abby's Dream
www.AbbysDream.com was created because of a very extraordinary girl named Abby Wilson. Abby is 13 years old and has been fighting lung cancer for FOUR years!
Abby’s Dream was created to bring awareness to lung cancer and that it can affect people of ALL ages - even if they have NEVER smoked or been around people who smoked.
They will hold their first walk on Saturday, April 30, 2011 at Tattnall Academy in Macon, Georgia. Learn more at www.AbbysDream.com.
They also have a Facebook Fan Page at
http://www.facebook.com/pages/Abbys-Dream/178387988870449.
Twilight Moms of Middle Georgia has adopted Abby as their Jay’s Hope Sweetheart and they plan to help do all the legwork involved in planning Abby’s Dream Walk.
For more information, contact Cindy Adrien of Abby's Dream at cindywhiteadrien@gmail.com.
Abby’s Dream was created to bring awareness to lung cancer and that it can affect people of ALL ages - even if they have NEVER smoked or been around people who smoked.
They will hold their first walk on Saturday, April 30, 2011 at Tattnall Academy in Macon, Georgia. Learn more at www.AbbysDream.com.
They also have a Facebook Fan Page at
http://www.facebook.com/pages/Abbys-Dream/178387988870449.
Twilight Moms of Middle Georgia has adopted Abby as their Jay’s Hope Sweetheart and they plan to help do all the legwork involved in planning Abby’s Dream Walk.
For more information, contact Cindy Adrien of Abby's Dream at cindywhiteadrien@gmail.com.
Wednesday, January 26, 2011
Looking beyond smoking, lung-cancer activists want early detection and treatment
by Laura Ungar
This article originally published as a special to The Washington Post on Monday, January 24, 2011.
After battling lung cancer and losing her sister to the disease, Marilyn Martens likes to hear the public-health community rail against smoking.
But she says anti-tobacco messages can't be the sole weapon against America's deadliest cancer; the focus needs to be widened to better emphasize early detection and treatment, too.
"It's really going to have to be all of these things," said Martens, 52, of Rockville, who underwent surgery for lung cancer in 2008. "I think there's a long way to go."
Martens is one of a growing number of lung cancer survivors, victims' relatives and advocacy groups calling for a greater, more comprehensive focus on the disease - similar to the multi-pronged approach to breast cancer.
Lung cancer killed 158,683 people in 2007, according to the Centers for Disease Control and Prevention. Five-year survival for lung cancer is 15.8 percent, up only slightly from 13 percent 35 years ago.
Doctors said there have been promising developments in treatment and early-detection research in recent years. But awareness of this progress is clouded by the overwhelming role that smoking plays in the disease, many say, an issue reemphasized in a Surgeon General's report last month. The report said that tobacco smoke contains at least 70 chemicals and compounds that cause cancer and that there is no "risk-free level of exposure" to tobacco smoke.
"We have a public-health epidemic that cannot be addressed with stop-smoking alone," said Laurie Fenton-Ambrose, president and chief executive of the Lung Cancer Alliance, a nonprofit advocacy group based in Washington. She said early detection and treatment are also crucial to reducing deaths.
But as they push for more attention to lung cancer, activists face a persistent stigma. "It's hard to digest that lung cancer is seen as the cancer you give yourself," said Martens, who was once a light smoker.
"No one deserves this disease," added Fenton-Ambrose.
Among other obstacles are a dearth of survivors to be voices for the cause and a lack of money. According to the alliance, federal research money for lung cancer from the National Institutes of Health, the Centers for Disease Control and Prevention and the Department of Defense totaled $218 million in 2010, compared with $1.15 billion for breast cancer.
But survivors said they are learning lessons from breast cancer activists and others who have successfully lobbied for money and attention to their causes. And doctors pointed out that there is plenty of overlap: Research on one cancer often leads to developments in others.
Fenton-Ambrose said she's determined that lung cancer comes out of the shadows. "Our movement for lung cancer has just begun," she said.
State governments are spending $517.9 million in fiscal 2011 to discourage the use of tobacco, according to the Campaign for Tobacco-Free Kids. And the CDC recommends that states should spend far more: $3.7 billion. Federal and state governments have also been raising cigarette taxes; the federal tax is now just over a dollar a pack.
Blame and stigma
Despite recent prevention efforts, adult smoking has plateaued in the past several years after dropping from 42 percent in the mid-1960s. The most recent federal numbers show that 20.6 percent of U.S. adults were cigarette smokers in 2009.
Current lung cancer rates reflect past smoking levels, since lung cancer can take many years, even decades, to develop. Up to 85 percent of cases are linked to smoking, medical experts say, although sometimes the cause is unknown and secondhand smoke, radon and asbestos are also culprits.
"One can actually say we have a better knowledge of how to prevent lung cancer than any other cancer," said Otis Brawley, the chief medical officer for the American Cancer Society.
But he said the blame and stigma surrounding the disease is unfair. He said that most people get hooked on cigarettes as impressionable teenagers and that quitting is extremely difficult because nicotine is more addictive than cocaine.
And, he said, those already sickened deserve research that gives them better odds of survival.
"Our approach to lung cancer should not just be anti-smoking research," Brawley said.
Brawley said recent years have brought promising progress on treating the disease. He pointed to Paul Bunn at the University of Colorado Cancer Center outside Denver and his work on lung cancer prognosis and selection of treatment.
Bunn is the principal investigator of his university's specialized program on lung cancer research, which is funded by the National Cancer Institute.
That specialized program is one of a growing number focusing on the disease. In Kentucky, which has the nation's highest rates of lung cancer and ties with West Virginia for the highest smoking rate, a 20-year initiative created by the state legislature funnels a small fraction of the state's tobacco-settlement funds into research. The 1998 multi-state tobacco settlement with tobacco companies has been estimated at $246 billion over the first 25 years. Scientists at the universities of Louisville and Kentucky are working on vaccines for the prevention and treatment of lung cancer, drugs based on novel ways of attacking the disease and new ways of finding it early.
A cure remains distant, scientists said, but early-detection research promises more-immediate benefits. A large study released in November showed that a type of advanced CT imaging can help reduce lung cancer deaths by 20 percent among heavy smokers. The imaging is much more sensitive than the commonly used chest X-ray.
Building momentum
One reason lung cancer remains so deadly is that it's often caught late.
Martens said she was extremely lucky to find her cancer early. Spurred by her sister's diagnosis, with no symptoms except for a tugging in her sternum, Martens had a regular CT scan that found a mass on her left lung. She needed surgery but not chemotherapy or radiation.
"I am the poster child for early detection," Martens said.
Nancy Alvey, a 58-year-old former smoker from Louisville, received a diagnosis of lung cancer about five years ago, after coughing up blood for two days. An X-ray found two spots in and around her right lung. She underwent surgery to remove the upper-right lobe of the lung and several lymph nodes. She suffered infections and needed four rounds of chemotherapy.
Alvey, who is now in remission, agreed with Martens that lung cancer is too often mentioned only in the context of smoking, with early detection and treatment left out of the discussion.
"While smoking is there, it's not the only thing," said Alvey, who works with the Lung Cancer Alliance and has also volunteered to speak with young people about avoiding tobacco. "It's a cancer just like breast cancer, and it deserves the same type of awareness."
Activism for breast cancer offers lessons for those seeking to elevate the cause of lung cancer.
"Our No. 1 strength is our grass-roots network," said Diana Rowden, survivorship and outcomes vice president at Dallas-based Susan G. Komen for the Cure, one of the best-known breast cancer organizations. "That didn't happen overnight. It started at the community level and spread that way."
She said the organization's Race for the Cure has also propelled it forward. The first one was held in 1983 in Dallas and attracted 800 people. In 2010, more than 140 races attracted more than 1.6 million participants worldwide.
"The race is very visible," Rowden said. "People are seeing women are surviving breast cancer and are healthy and active."
Another key is the organization's relationship with corporate partners.
Rowden predicted it wouldn't take decades for the lung cancer movement to reach the level of success of the breast cancer movement because others have helped light a path. She said breast cancer activists learned from AIDS activists who came before them.
Lung cancer activists say their work is starting to pay off.
Fenton-Ambrose said her group now has five state chapters. Among other activities, it has raised more than half a million dollars for research, education, advocacy and treatment through its annual run/walk.
Along with other advocates, the organization pushed for the Defense Department's Lung Cancer Research Program. The initiative was established to promote research on finding, treating and managing early lung cancer after officials concerned about tobacco use among military personnel and about troops' exposure to carcinogens in the field. Congress appropriated $35 million to the program over its first two years, and Fenton-Ambrose hopes an additional $16 million will be appropriated for 2011.
"I think there's a long way to go," said Martens, who has participated in recent lung cancer walks and watched them grow year by year. "But I think there's some momentum."
Ungar is a medical writer at the Courier-Journal in Louisville.
Thursday, January 20, 2011
Monday, January 3, 2011
Blood Test to Spot Cancer Gets Big Boost from J & J
Originally Published by The Associated Press on Monday, January 3rd, 2011
By MARILYNN MARCHIONE
BOSTON — A blood test so sensitive that it can spot a single cancer cell lurking among a billion healthy ones is moving one step closer to being available at your doctor's office.
Boston scientists who invented the test and health care giant Johnson & Johnson will announce Monday that they are joining forces to bring it to market. Four big cancer centers also will start studies using the experimental test this year.
Stray cancer cells in the blood mean that a tumor has spread or is likely to, many doctors believe. A test that can capture such cells has the potential to transform care for many types of cancer, especially breast, prostate, colon and lung.
Initially, doctors want to use the test to try to predict what treatments would be best for each patient's tumor and find out quickly if they are working.
"This is like a liquid biopsy" that avoids painful tissue sampling and may give a better way to monitor patients than periodic imaging scans, said Dr. Daniel Haber, chief of Massachusetts General Hospital's cancer center and one of the test's inventors.
Ultimately, the test may offer a way to screen for cancer besides the mammograms, colonoscopies and other less-than-ideal methods used now.
"There's a lot of potential here, and that's why there's a lot of excitement," said Dr. Mark Kris, lung cancer chief at Memorial Sloan-Kettering Cancer Center in New York. He had no role in developing the test, but Sloan-Kettering is one of the sites that will study it this year.
Many people have their cancers diagnosed through needle biopsies. These often do not provide enough of a sample to determine what genes or pathways control a tumor's growth. Or the sample may no longer be available by the time the patient gets sent to a specialist to decide what treatment to prescribe.
Doctors typically give a drug or radiation treatment and then do a CT scan two months later to look for tumor shrinkage. Some patients only live long enough to try one or two treatments, so a test that can gauge success sooner, by looking at cancer cells in the blood, could give patients more options.
"If you could find out quickly, 'this drug is working, stay on it,' or 'this drug is not working, try something else,' that would be huge," Haber said.
The only test on the market now to find tumor cells in blood — CellSearch, made by J&J's Veridex unit — just gives a cell count. It doesn't capture whole cells that doctors can analyze to choose treatments.
Interest in trying to collect these cells soared in 2007, after Haber and his colleagues published a study of Mass General's test. It is far more powerful than CellSearch and traps cells intact. It requires only a couple of teaspoons of blood and can be done repeatedly to monitor treatment or determine why a drug has stopped working and what to try next.
"That's what got the scientific community's interest," Kris said. Doctors can give a drug one day and sample blood the next day to see if the circulating tumor cells are gone, he explained.
The test uses a microchip that resembles a lab slide covered in 78,000 tiny posts, like bristles on a hairbrush. The posts are coated with antibodies that bind to tumor cells. When blood is forced across the chip, cells ping off the posts like balls in a pinball machine. The cancer cells stick, and stains make them glow so researchers can count and capture them for study.
The test can find one cancer cell in a billion or more healthy cells, said Mehmet Toner, a Harvard University bioengineer who helped design it. Researchers know this because they spiked blood samples with cancer cells and then searched for them with the chip.
Studies of the chip have been published in the journals Nature, the New England Journal of Medicine and Science Translational Medicine. It is the most promising of several dozen that companies and universities are rushing to develop to capture circulating tumor cells, said Bob McCormack, technology chief for Veridex.
The agreement announced Monday will have Veridex and J&J's Ortho Biotech Oncology unit work to improve the microchip, including trying a cheaper plastic to make it practical for mass production. No price goal has been set, a company official said, but the current CellSearch test costs several hundred dollars.
The companies will start a research center at Mass General and will have rights to license the test from the hospital, which holds the patents.
In a separate effort, Mass General, Sloan-Kettering, University of Texas M.D. Anderson Cancer Center in Houston and Dana-Farber Cancer Institute in Boston will start using the test this year. They are one of the "dream teams" sharing a $15 million grant from the Stand Up to Cancer telethon, run by the American Association for Cancer Research.
Already, scientists have been surprised to find that more cancer patients harbor these stray cells than has been believed. In one study, the test was used on men thought to have cancer confined to the prostate, "but we found these cells in two-thirds of patients," Toner said.
This might mean that cancer cells enter the blood soon after a tumor starts, or that more cancers have already spread but are unseen by doctors.
Or it could mean something else entirely, because researchers have much to learn about these cells, said Dr. Minetta Liu, a breast cancer specialist at Georgetown University's Lombardi Comprehensive Cancer Center. She led a session on them at the recent San Antonio Breast Cancer Symposium and has been a paid speaker for Veridex. She hopes the cells will someday aid cancer screening.
"The dream is, a woman comes in for her mammogram and gets a tube of blood drawn," so doctors can look for cancer cells in her blood as well as tumors on the imaging exam, she said.
That's still far off, but Mass General's test already is letting doctors monitor patients without painful biopsies. Like Greg Vrettos, who suffered a collapsed lung from a biopsy in 2004, when he was diagnosed with lung cancer.
"It had spread to both lungs and they couldn't operate," said Vrettos, 63, a nonsmoker and retired electrical engineer from Durham, N.H. Tests from the biopsy showed that he was a good candidate for the drug Iressa, which he has taken ever since. He goes to Boston every three months for CT scans and the blood test.
"They could look at the number of cancer cells and see that it dropped over time. It corresponded with what the scans were showing," Vrettos said of doctors looking at his blood tests.
The test also showed when he had a setback last January and needed to have his treatment adjusted.
"I think it's going to be revolutionary," he said of the test.
Wednesday, December 22, 2010
The Inspirational Story of Zheng Cao
ABC's Good Morning America. Wednesday, December 22nd, 2010.
Help create more stories like this one. www.NobodyDeservesIt.com
Help create more stories like this one. www.NobodyDeservesIt.com
Monday, December 13, 2010
Lung Cancer News
Remember, you can stay on top of lung cancer in the news by following our Google Shared items at http://www.google.com/reader/shared/gaetafund.
Subscribe to:
Posts (Atom)